Takeda Pharmaceutical announced Friday morning that it intends to acquire TiGenix NV (TIG) in a deal valued at approximately 520 million euros.
TiGenix gapped open dramatically higher Friday, but moved in a narrow range throughout the session. The stock closed up by 17.05 at $40.73 on strong volume. TiGenix soared to a new high for the year.
by RTT Staff Writer
For comments and feedback: editorial@rttnews.com